About the Role
The journal is now seeking two new Editor-in-Chiefs with expertise in immunology, as well as the passion to drive the journal forward in an exciting period of change. The new Editor-in-Chief role will start on January 1st, 2023. It is a significant role, with a high profile, but one that is achievable within a continuing busy working academic timetable.
The successful candidate will be responsible for editorial oversight and decision-making on submissions. He, or she, will have the authority to accept articles following successful peer review, and will ensure that reviewers and authors adhere to the Journal’s Code of Publishing Ethics.
This editor will be working in partnership with the editorial board to ensure that authors receive a superior experience. Taylor & Francis will provide remuneration for the role.
Taylor & Francis will also organize regular board meetings, and we will supply annual reports reflecting on the performance of the Journal. Training/onboarding will be arranged.